<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03074617</url>
  </required_header>
  <id_info>
    <org_study_id>LTE-Sleep</org_study_id>
    <nct_id>NCT03074617</nct_id>
  </id_info>
  <brief_title>Electromagnetic Field Effects of Mobile Communication (LTE) on Sleep in the Context of Genetic Variation</brief_title>
  <official_title>Electromagnetic Field Effects of Mobile Communication (LTE) on Sleep in the Context of Genetic Variation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of electromagnetic fields of the latest standard in mobile communication (long&#xD;
      term evolution, LTE) on sleep is studied in healthy, young individuals.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 31, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>electroencephalographic power during sleep after LTE exposure</measure>
    <time_frame>up to 9 hours (approximately 11 p.m. to 8 a.m.)</time_frame>
    <description>electroencephalogram (EEG)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>LTE field</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sham field</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>LTE field</intervention_name>
    <description>electromagnetic field of the latest standard in mobile communication (long term evolution, LTE)</description>
    <arm_group_label>LTE field</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sham field</intervention_name>
    <description>no electromagnetic field</description>
    <arm_group_label>sham field</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-30 years&#xD;
&#xD;
          -  German knowledge (reading and writing)&#xD;
&#xD;
          -  Right-handedness&#xD;
&#xD;
          -  Body mass index (BMI) 18.5-25.0 kg/m2&#xD;
&#xD;
          -  Mobile communication (phone calls) less than 2 hours per week&#xD;
&#xD;
          -  Moderate alcohol consumption (less than 5 alcoholic beverages per week)&#xD;
&#xD;
          -  Moderate caffeine consumption (less than 5 caffeinated foods per day, e.g. coke,&#xD;
             coffee, energy drinks, green or black tea, chocolate)&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Travels across more than 2 time zones in the last 30 days or during the study&#xD;
&#xD;
          -  Nocturnal shift work&#xD;
&#xD;
          -  Extreme chronotype or extreme sleep duration (less than 5 hours or more than 10 hours&#xD;
             on average)&#xD;
&#xD;
          -  Sleep disorders or problems&#xD;
&#xD;
          -  Severe acute or chronic neurological, mental or general health disorders, which might&#xD;
             impair the participant's safety or affect the study's outcome&#xD;
&#xD;
          -  Use of medication (regular or during the study), which might affect the study's&#xD;
             outcome&#xD;
&#xD;
          -  Recreational drug use&#xD;
&#xD;
          -  Smoking (or other tobacco products)&#xD;
&#xD;
          -  Severe skin allergies&#xD;
&#xD;
          -  Relevant findings in physical examination or during the screening night (e.g. sleep&#xD;
             disorders)&#xD;
&#xD;
          -  Participation in an other clinical trial in the last 30 days or during the study&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans-Peter Landolt</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich, Institute of Pharmacology and Toxicology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Zurich, Institute of Pharmacology and Toxicology</name>
      <address>
        <city>Zurich</city>
        <zip>8057</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 23, 2017</study_first_submitted>
  <study_first_submitted_qc>March 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2017</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

